^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersBIOMARKER:
KIT V559A
i
Other names: KIT, KIT proto-oncogene receptor tyrosine kinase, C-Kit, CD117, PBT, SCFR, Stem Cell Factor Receptor, V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
27d
Testing the Use of Nilotinib and Paclitaxel as a Treatment for Patients With Prior Taxane Treatment, A ComboMATCH Treatment Trial (clinicaltrials.gov)
P2, N=40, Active, not recruiting, National Cancer Institute (NCI) | Suspended --> Active, not recruiting
Enrollment closed
|
PDGFRA (Platelet Derived Growth Factor Receptor Alpha)
|
PDGFRA D842V • KIT L576P • KIT K642E • KIT V559 • KIT V559A • KIT W557
|
paclitaxel • Tasigna (nilotinib)
11ms
Testing the Use of Nilotinib and Paclitaxel as a Treatment for Patients With Prior Taxane Treatment, A ComboMATCH Treatment Trial (clinicaltrials.gov)
P2, N=40, Suspended, National Cancer Institute (NCI) | Recruiting --> Suspended
Trial suspension
|
PDGFRA (Platelet Derived Growth Factor Receptor Alpha)
|
PDGFRA D842V • KIT L576P • KIT K642E • KIT V559 • KIT V559A • KIT W557
|
paclitaxel • Tasigna (nilotinib)
over1year
Testing the Use of Nilotinib and Paclitaxel as a Treatment for Patients With Prior Taxane Treatment, A ComboMATCH Treatment Trial (clinicaltrials.gov)
P2, N=40, Recruiting, National Cancer Institute (NCI) | Initiation date: Sep 2023 --> Dec 2023
Trial initiation date
|
PDGFRA (Platelet Derived Growth Factor Receptor Alpha)
|
PDGFRA D842V • KIT L576P • KIT K642E • KIT V559 • KIT V559A • KIT W557
|
paclitaxel • Tasigna (nilotinib)
over1year
Testing the Use of Nilotinib and Paclitaxel as a Treatment for Patients With Prior Taxane Treatment, A ComboMATCH Treatment Trial (clinicaltrials.gov)
P2, N=40, Recruiting, National Cancer Institute (NCI) | Not yet recruiting --> Recruiting
Enrollment open
|
PDGFRA (Platelet Derived Growth Factor Receptor Alpha)
|
PDGFRA D842V • KIT L576P • KIT K642E • KIT V559 • KIT V559A • KIT W557
|
paclitaxel • Tasigna (nilotinib)
over1year
Testing the Use of Nilotinib and Paclitaxel as a Treatment for Patients With Prior Taxane Treatment, A ComboMATCH Treatment Trial (clinicaltrials.gov)
P2, N=40, Recruiting, National Cancer Institute (NCI) | Initiation date: Jun 2023 --> Sep 2023
Trial initiation date
|
PDGFRA (Platelet Derived Growth Factor Receptor Alpha)
|
PDGFRA D842V • KIT L576P • KIT K642E • KIT V559 • KIT V559A • KIT W557
|
paclitaxel • Tasigna (nilotinib)
over1year
Testing the Use of Nilotinib and Paclitaxel as a Treatment for Patients With Prior Taxane Treatment, A ComboMATCH Treatment Trial (clinicaltrials.gov)
P2, N=40, Recruiting, National Cancer Institute (NCI) | Not yet recruiting --> Recruiting | Initiation date: Dec 2022 --> Jun 2023
Enrollment open • Trial initiation date
|
PDGFRA (Platelet Derived Growth Factor Receptor Alpha)
|
PDGFRA D842V • KIT L576P • KIT K642E • KIT V559 • KIT V559A • KIT W557
|
paclitaxel • Tasigna (nilotinib)
Share via
